Quick Asked: Unum Therapeutics Contact Us?

Are you searching for Unum Therapeutics Contact Us? By using our below available official links ( which are always up to date), you can find contact information without any difficulty. It may list Phone number, Mobile phone, Email Address & Customer service information.
Last update: 10 May, 2024 218 Views

Where is unum therapeutics located? UNUM Therapeutics headquarters is located at 200 Cambridgepark Dr #3100, Cambridge. Where are UNUM Therapeutics offices? UNUM Therapeutics has an office in Cambridge.

How do i contact unum? Call us at 866-679-3054 (8 a.m. to 8 p.m. ET, Monday through Friday) if you have any questions about your Unum coverage. For questions related to coronavirus, click here. Covered through a prior employer? If you have Unum coverage through a previous employer, reach out to us about your benefits by submitting your question.

Who is the ceo of unum life insurance company? Richard McKenney has led Unum as its CEO since April 1, 2015. Union Mutual Life Insurance was incorporated in 1848 in Maine. The company issued its first policy, which covered the life of founder and company president Elisha B. Pratt for $5000, on October 1, 1849.

How can i learn more about unum employee benefits? Talk with a Unum sales representative about your company's employee benefits plan. To learn more about offering Unum benefits to your clients, get in touch with your nearest field office. Do you need to check the status of your claim or leave? Or do you just have questions about your policy? We can help.

Listing Results Unum Therapeutics Contact Us? Question Answers

Unum Therapeutics Announces Company Name Change to ...

Unum Therapeutics Inc. ("Unum") (NASDAQ: UMRX), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its name change to Cogent

Unum Moves to New Headquarters HighProfile

Unum Therapeutics is a company developing a universal cellular immunotherapy to treat multiple cancers. The company’s new office and laboratory facilities, located at 200 Cambridge Park Drive, were designed to help facilitate anticipated growth to more than 80 employees in the near future. The new 33,000sf of space was designed specifically

Unum Therapeutics Transfers BOXR CellBased Therapy

Unum Therapeutics is a biopharmaceutical company focused on developing a pipeline of novel, best-in-class precision kinase inhibitors for a range of patients living with cancer and other unmet

Cogent Biosciences Crunchbase Company Profile & ...

(617) 843-5032 Also Known As UNUM Therapeutics Legal Name Cogent Biosciences, Inc. Stock Symbol NASDAQ:UMRX Company Type For Profit Contact Email [email protected] Phone Number (617) 843-5032 Cogent Biosciences uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight ...

Unum Therapeutics Announces Company Cogent Biosciences

CAMBRIDGE, Mass., Oct. 5, 2020 /PRNewswire/ -- Unum Therapeutics Inc. ("Unum") (NASDAQ: UMRX), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its name change to Cogent Biosciences, Inc. ("Cogent"). Beginning on October 6, 2020, Cogent will trade on NASDAQ ...

Unum Therapeutics changes name to Cogent Biosciences S&P

Unum Therapeutics Inc. is changing its name to Cogent Biosciences Inc. The biotechnology company's ticker symbol on the Nasdaq stock exchange will also change from UMRX to COGT, effective Oct. 6. The name change follows the company's merger with privately held Kiq Bio LLC in July. Cogent will continue as a precision therapy developer and focus

Unum Therapeutics Announces Company Business Insider

Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress ...

DEF 14A sec.gov

UNUM THERAPEUTICS INC. 200 Cambridge Park Drive, Suite 3100 . Cambridge, Massachusetts 02140 . NOTICE OF SPECIAL MEETING OF STOCKHOLDERS . To be held March 9, 2020 . To the Stockholders of Unum Therapeutics Inc.: We cordially invite you to attend a Special Meeting of Stockholders of Unum Therapeutics Inc.

FORM D SEC

617-945-5576 Unum Therapeutics Inc. Street Address 1 Street Address 2; 200 CAMBRIDGE PARK DRIVE: SUITE 3100: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; CAMBRIDGE: MASSACHUSETTS: 02140: 617-945-5576

BRIEFUnum Therapeutics Says Terminated Employment Of

* UNUM THERAPEUTICS - ON MAY 14, TERMINATED EMPLOYMENT OF MATTHEW OSBORNE, CO'S CHIEF FINANCIAL OFFICER, EFFECTIVE AS OF MAY 29, 2020 Source text: (https://bit.ly/2T5RbHi) Further company coverage:

Unum Therapeutics Announces Company Name PR ...

Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress Cogent Biosciences is focused on the design of rational precision

Unum Therapeutics ZIP 02142, NAICS 541714, SIC 8731

Business Overview "Unum Therapeutics" of Cambridge, MA 02142 operates primarily in SIC Code 8731 - Commercial Physical and Biological Research and NAICS Code 541714 - Research and Development in Biotechnology (except Nanobiotechnology).Unum Therapeutics is a small-sized business with medium revenue, that is new in its industry.

UNUM Therapeutics Company Profile Craft

UNUM Therapeutics has 56 employees at their 1 location and $8.36 M in annual revenue in FY 2017. See insights on UNUM Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Unum Therapeutics Inc. Announces Acquisition of Kiq LLC

(855) 859-2056 To access the conference call recording, please dial (855) 859-2056 (toll-free) or (404) 537-3406. The archived recording will remain available for replay for 30 days. For more information on the

Unum Therapeutics FierceBiotech

Unum CEO Charles Wilson Unum Therapeutics CAR-T is all the rage in oncology circles, but Unum Therapeutics is looking to use its technology to broaden the impact of engineered T cells CEO:

Unum Therapeutics Announces New Appointments to Yahoo

Unum Therapeutics Inc. (UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies to treat cancer based on its novel T cell technology platforms

Did the information help you? If so, please share!
If you think the information on this page has been helpful to you, would you be willing to share it? Your sharing is the driving force for our continuous work.